Eli Lilly (LLY +3.38%) has had a tumultuous year. The pharmaceutical giant lagged the market for much of it, due to worse-than-expected financial results and a clinical setback. However, the Eli Lilly ...

Stock splits are exciting, but fundamentals are more important. But while the split puts Netflix shares in reach for employees and investors who might not have access to fractional shares, it doesn't ...